Propanc reports preclinical pancreatic cancer data for PRP drug candidate

Go back to Propanc reports preclinical pancreatic cancer data for PRP drug candidate
(NASDAQ: PPCB) Delayed: 0.28 +0.01 (3.70%)
Previous Close $0.27    52 Week High $ 
Open $0.28    52 Week Low $ 
Day High $0.28    P/E N/A 
Day Low $0.25    EPS $ 
Volume 248,917